Advanced search×

Nocturnal aspects of narcolepsy with cataplexy.

Giuseppe G Plazzi, Leonardo L Serra, and Raffaele R Ferri

Sleep Med Rev 12(2):109-28 (2008) PMID 18282773

Even though the most impressive manifestation of narcolepsy is excessive sleepiness, paradoxically a significant number of patients have trouble sleeping at night. A wide array of alterations can affect the night-time sleep of a narcoleptic patient, and the aim of this review is to increase awareness on this issue, thereby enhancing the care of narcoleptic patients by more specific approaches to their disturbed night sleep. This review covers a broad variety of nocturnal sleep features in narcolepsy. Starting from animal models and the clinical features of patients, the paper then discusses the many comorbid conditions found in narcolepsy at night, the most advanced methods of analysis and the few recent advances in the specific treatment of night sleep in narcoleptic patients.

DOI: 10.1016/j.smrv.2007.08.010
Version: za2963e q8zab q8zbb q8zc0 q8zdb q8ze1 q8zf8 q8zg4

Similar articles you may find interesting…

  1. Pharmacotherapy options for cataplexy.
    Régis Lopez and Yves Dauvilliers

    Expert Opin Pharmacother (2013) PMID 23521426

    Narcolepsy with cataplexy is a rare disabling sleep disorder characterized by two major symptoms: excessive daytime sleepiness and cataplexy characterized by a sudden bilateral loss of voluntary muscular tone triggered by strong positive emotional factors. Pathophysiological studies have shown that...
  2. Colour also matters for nocturnal birds: owlet bill coloration advertises quality and influences parental feeding behaviour in little owls.
    J M Avilés and D Parejo

    Oecologia (2013) PMID 23443357

    We test the hypothesis that yellow bill coloration of owlets of the nocturnal little owl Athene noctua may function as a chromatic signal revealing to parents aspects of quality of their offspring. In a first step, we examined physical variation in bill coloration and its covariation with owlet qual...
  3. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status.
    Michihiro M Mieda and Takeshi T Sakurai

    CNS Drugs 27(2):83-90 (2013) PMID 23359095

    Orexin A and orexin B are hypothalamic neuropeptides initially identified as endogenous ligands for two orphan G-protein coupled receptors (GPCRs). They play critical roles in the maintenance of wakefulness by regulating function of monoaminergic and cholinergic neurons that are implicated in the reg...